Polymorphism of apolipoprotein E gene and atherosclerosis

   Polymorphism genes assay is of importance for estimation of predisposition to multifactorial diseases on population and individual level. We investigated apolipoprotein E polymorphism and its influence on a lipid metabolism in population of Novosibirsk city (the largest scientific and industrial centre of West Siberia). Polymorphism of apolipoprotein E (APOE) gene was studied in sample of inhabitants of Novosibirsk city aged 25‐64 years (n=611), in patients with nonfatal myocardial infarction (n=141), in patients with nonfatal stroke (n=167), in men with sudden cardiac death (n=250) and in long‐livers of the same region (n=97). A lipid profile depending on APOE genotypes was analyzed in a population and in a group of long‐livers of Novosibirsk. In male population 25‐64 years of age dynamics (changes) of frequencies APOE genotypes are not revealed. In comparison with frequencies of APOE genotypes in men is more senior than 83 years has appeared, that the frequency of a genotype ε3/ε4 has decreased 4 times, and the frequency of a genotype ε2/ε3 has increased 2 times. Among the persons of senile age and long‐livers, both men, and women the carriers of a genotype ε4/ε4 on APOE gene are not revealed. The highest level of total cholesterol in population of Novosibirsk is characteristic for a genotype APOE ε4/ε4. The introduction of genotyping of human apolipoprotein E in a population of Novosibirsk is expedient.

1. Воевода М. И. Некоторые молекулярно‐генетические аспекты атерогенеза в этнических группах Сибири / М. И. Воевода [и др.] – В: Сборник трудов юбилейной научной сессии НИИ терапии СО РАМН. – 2002. – 45‐50.

2. Короленко Ц. П. Молекулярно‐генетические факторы риска болезни Альцгеймера / Ц. П. Короленко [и др.] // Журнал неврологии и психиатрии им. Корсакова. – 2001. – 1: 65‐68.

3. Никитин Ю. П. Сердечно‐сосудистые заболевания в Сибири: 10‐летние тренды и определяющие факторы (Сибирская МОНИКА) / Ю. П. Никитин [и др.] – В: кн. Диагностика, лечение и профилактика сердечно‐сосудистых заболеваний. – Новосибирск, 1996. – 103‐104.

4. Оганов Р. Г. Первичная профилактика ИБС / Р. Г. Оганов. – М: Медицина, 1990.

5. Титова Г. И. Взаимодействие холестерина с апопротеином Е – аргининбогатым белком липопротеинов очень низкой плотности / Г. И. Титова [и др.] // Биохимия. – 1980. – 45: 51‐55.

6. Шабалин А. В. Полиморфизм гена ангиотензин‐превращающего фермента и гена аполипопротеина Е у долгожителей города Новосибирска / А. В. Шабалин // Успехи геронтологии. – 2003. – 12: 77‐81.

7. Bullido M. J., Artiga M. J., Recuero M., Sastre I. et al. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer’s dementia. Nature genetics 1998; 18: 69‐71.

8.

9. Corbo R. M., Scacchi R. Apolipoprotein E (APOE) allele distribution in the world: is APOE*4 a "thrifty" allele? Ann. Hum. Genet. 1999; 63: 301‐310.

10. Corbo R. M., Scacchi R., Rickards O. et al. An investigation of human apolipoproteins B and E polymorphisms in two African populations from Ethiopia and Benin. Am. J. Human. Biol. 1999; 11 (3): 297‐304.

11. Corella D., Guillen M., Saiz C. et al. Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locus. J. Lipid Res. 2002; 43: 416‐427.

12. Davignon J., Gregg R. E., Sing C. F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1‐21.

13. van Erpecum K. J., Portincasa P., Dohlu M. H. et al. Biliary pronucleating proteins and apolipoprotein E in cholesterol and pigment stone patients. J. Hepatol 2003; 39 (1): 7‐11.

14. Frisoni G. B., Louhija J., Geroldi C., Trabucchi M. Longevity and the ε 2 Allele of Apolipoprotein E: The Finnish Centenarians Study. J. Gerontol. A Biol. Sci. Med. Sci. 2001; 56 (2); 75 ‐ 78.

15. Hofman A., Ott A., Breteler M. M. B. et al. Atherosclerosis, apolipoprotein E and prevalence of dementia and Alzheimer`s disease in the Rotterdam study. Lancet 1997; 349; 151‐154.

16. Jaramillo‐Correa J. P., Keyex G., Ruiz‐Garcia M. et al. Population genetic analysis of the genes APOE, APOB (3'VNTR) and ACE in some black and amerindian communities from Columbia. Hum. Hered. 2001; 52: 14‐33.

17. Ilveskoski E., Perola M., Lehtimaki T. et al. Age‐Dependent Association of Apolipoprotein E Genotype With Coronary and Aortic Atherosclerosis in Middle‐Aged Men: An Autopsy Study. Circulation 1999; 100: 608‐613.

18. Kukull W., Martin G. M. APO E Polymorphisms and Late‐Onset Alzheimer Disease. JAMA 1998; 279 (10): 788‐789.

19. Lambert J.‐C., Brousseau T., Defoss V., et al. Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations – the ECTIM Study. Hum. Mol. Genet 2000; 9 (1): 57‐61.

20. Lambert J.‐C., Mann D., Goumidi L., Harris J. et al. Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer’s disease. Lancet 2001; 357: 608‐609.

21. Larson I. A., Ordovas J. M., De Luca C. et al. Association of apolipoprotein E genotype with plasma apo E levels. Atherosclerosis 1999; 148 (2).

22. Laws S. M., Hone E., Taddei K., et al. Variation at the APOE 491 promoter locus is associated with altered brain levels of apolipoprotein E. Molecular Psychiatry 2002; 7: 886–890.

23. Lucotte G., Loirat F., Hazout S. Pattern of gradient of apolipoprotein E allele *4 frequencies in Western Europe. Hum. Biol. 1997; 69: 253 262.

24. Pahnke J., Walker L. C., Schroeder E., et al. Cerebral β‐amyloid deposition is augmented by the –491AA promoter polymorphism in non‐demented elderly individuals bearing the apolipoprotein E ε4 allele. Acta Neuropathol 2003; 105: 25‐29.

25. Paik Y.‐K., Chang D. J., Reardon C. A., et al. Nucleotide sequence and structure of the human apolipoprotein E gene. Proc. Natl. Acad. Sci. USA 1989; 82: 3445‐3449.

26. Reardon C. A. Differential metabolism of apolipoprotein E isoproteins. J. Lab. Clin. Med 2002;. 140 (5): 301‐302.

27. Srinivasan S. R., Ehnholm C., Elkasabany A., Berenson G. Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood to adulthood: the Bogalusa Heart Study. Atherosclerosis 1999; 143: 435‐443.

28. Strittmatter W., Saunders A., Schmechel D. et al. Apolipoprotein E: High avidity binding to b‐amyloid and increased frequency of type 4 allele in late‐onset familial Alzheimer disease. Proc. Nat. Acad. Sci. 1993; 90: 1977‐1981.

29. Utermann G., Hess M., Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man. Nature 1977; 269: 604‐607.

30. Xhignesse M., Lussier‐Cacan S., Sing C. F. et al. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler. Thromb 1991; 11: 1100‐1110.

31. Zekraoui L., Lagarde J. P., Raisonnier A. et al. High frequency of the apolipoprotein E *4 allele in African pygmies and most of the African populations in sub‐Saharan Africa. Hum. Biol 1997; 69: 575‐581.